- Home
- VZLA vs CCCC Comparison
VZLA vs CCCC Comparison
Compare VZLA & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VZLA
- CCCC
- Stock Information
- Founded
- VZLA 2017
- CCCC 2015
- Country
- VZLA Canada
- CCCC United States
- Employees
- VZLA N/A
- CCCC N/A
- Industry
- VZLA
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- VZLA
- CCCC Health Care
- Exchange
- VZLA Nasdaq
- CCCC Nasdaq
- Market Cap
- VZLA 487.1M
- CCCC 396.0M
- IPO Year
- VZLA N/A
- CCCC 2020
- Fundamental
- Price
- VZLA $1.76
- CCCC $3.95
- Analyst Decision
- VZLA Strong Buy
- CCCC Buy
- Analyst Count
- VZLA 3
- CCCC 6
- Target Price
- VZLA $4.33
- CCCC $10.67
- AVG Volume (30 Days)
- VZLA 1.3M
- CCCC 1.9M
- Earning Date
- VZLA 12-13-2024
- CCCC 10-31-2024
- Dividend Yield
- VZLA N/A
- CCCC N/A
- EPS Growth
- VZLA N/A
- CCCC N/A
- EPS
- VZLA N/A
- CCCC N/A
- Revenue
- VZLA N/A
- CCCC $33,668,000.00
- Revenue This Year
- VZLA N/A
- CCCC $75.79
- Revenue Next Year
- VZLA N/A
- CCCC N/A
- P/E Ratio
- VZLA N/A
- CCCC N/A
- Revenue Growth
- VZLA N/A
- CCCC 65.45
- 52 Week Low
- VZLA $1.07
- CCCC $3.61
- 52 Week High
- VZLA $2.40
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- VZLA 43.81
- CCCC 41.77
- Support Level
- VZLA $1.78
- CCCC $3.61
- Resistance Level
- VZLA $2.00
- CCCC $4.06
- Average True Range (ATR)
- VZLA 0.09
- CCCC 0.44
- MACD
- VZLA -0.00
- CCCC 0.01
- Stochastic Oscillator
- VZLA 15.52
- CCCC 22.82
About VZLA Vizsla Silver Corp.
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.